Molecular magnetic resonance imaging in cancer

被引:65
|
作者
Haris, Mohammad [1 ]
Yadav, Santosh K. [1 ]
Rizwan, Arshi [2 ]
Singh, Anup [3 ]
Wang, Ena [1 ]
Hariharan, Hari [4 ]
Reddy, Ravinder [4 ]
Marincola, Francesco M. [1 ]
机构
[1] Sidra Med & Res Ctr, Doha 26999, Qatar
[2] All India Inst Med Sci, New Delhi, India
[3] Indian Inst Technol, Ctr Biomed Engn, Delhi, India
[4] Univ Penn, Dept Radiol, Ctr Magnet Resonance & Opt Imaging, Philadelphia, PA 19104 USA
来源
关键词
Cancer; Magnetic resonance imaging; Magnetic resonance spectroscopy; Hyperpolarization; Chemical exchange saturation transfer (CEST) imaging; Reporter genes; Cancer immunotherapy; PROTON MR SPECTROSCOPY; CHOLINE PHOSPHOLIPID-METABOLISM; HUMAN BREAST-CANCER; DECOUPLED P-31 MRS; HUMAN BRAIN-TUMORS; IN-VIVO; PROSTATE-CANCER; COLORECTAL-CANCER; GENE-EXPRESSION; LUNG-CANCER;
D O I
10.1186/s12967-015-0659-x
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The ability to identify key biomolecules and molecular changes associated with cancer malignancy and the capacity to monitor the therapeutic outcome against these targets is critically important for cancer treatment. Recent developments in molecular imaging based on magnetic resonance (MR) techniques have provided researchers and clinicians with new tools to improve most facets of cancer care. Molecular imaging is broadly described as imaging techniques used to detect molecular signature at the cellular and gene expression levels. This article reviews both established and emerging molecular MR techniques in oncology and discusses the potential of these techniques in improving the clinical cancer care. It also discusses how molecular MR, in conjunction with other structural and functional MR imaging techniques, paves the way for developing tailored treatment strategies to enhance cancer care.
引用
收藏
页数:16
相关论文
共 50 条
  • [21] Molecular imaging techniques in magnetic resonance imaging and nuclear imaging
    Högemann, D
    Basilion, JP
    Weissleder, R
    RADIOLOGE, 2001, 41 (02): : 116 - +
  • [22] Prediction of Prostate Cancer Recurrence Using Magnetic Resonance Imaging and Molecular Profiles
    Shukla-Dave, Amita
    Hricalk, Hedvig
    Ishil, Nicole
    Moskowitz, Chaya S.
    Drobnjak, Marija
    Reuter, Victor E.
    Zakian, Kristen L.
    Scardino, Peter T.
    Cordon-Cardo, Carlos
    CLINICAL CANCER RESEARCH, 2009, 15 (11) : 3842 - 3849
  • [23] Magnetic resonance imaging correlation with molecular and epigenetic markers in assessment of breast cancer
    El-Rawy, Aya S.
    Abdallah, Hoda Y.
    Suliman, Marwa A.
    Habba, Mohamed R.
    Gad, Azza A.
    EGYPTIAN JOURNAL OF RADIOLOGY AND NUCLEAR MEDICINE, 2022, 53 (01):
  • [24] Magnetic Resonance Imaging Phenotypes of Breast Cancer Molecular Subtypes: A Systematic Review
    Ab Mumin, Nazimah
    Hamid, Marlina Tanty Ramli
    Wong, Jeannie Hsiu Ding
    Rahmat, Kartini
    Ng, Kwan Hoong
    ACADEMIC RADIOLOGY, 2022, 29 : S89 - S106
  • [25] The association of magnetic resonance imaging features with five molecular subtypes of breast cancer
    Nguyen, Van Thi
    Duong, Duc Huu
    Nguyen, Quang Thai
    Nguyen, Duy Thai
    Tran, Thi Linh
    Duong, Tra Giang
    EUROPEAN JOURNAL OF RADIOLOGY OPEN, 2024, 13
  • [26] Magnetic resonance molecular imaging for non-invasive precision cancer diagnosis
    Lu, Zheng-Rong
    CURRENT OPINION IN BIOMEDICAL ENGINEERING, 2017, 3 : 67 - 73
  • [27] Magnetic Resonance Imaging for Lung Cancer
    Koyama, Hisanobu
    Ohno, Yoshiharu
    Seki, Shinichiro
    Nishio, Mizuho
    Yoshikawa, Takeshi
    Matsumoto, Sumiaki
    Sugimura, Kazuro
    JOURNAL OF THORACIC IMAGING, 2013, 28 (03) : 138 - 150
  • [28] Magnetic resonance imaging and prostate cancer
    Cornud, F.
    Villers, A.
    Mongiat-Artus, P.
    Rebillard, X.
    Soulie, M.
    PROGRES EN UROLOGIE, 2008, 18 (10): : 621 - 633
  • [29] Magnetic resonance imaging of colorectal cancer
    Zagoria, RJ
    Wolfman, NT
    SEMINARS IN ROENTGENOLOGY, 1996, 31 (02) : 162 - 165
  • [30] Magnetic resonance imaging in prostate cancer
    S D Heenan
    Prostate Cancer and Prostatic Diseases, 2004, 7 : 282 - 288